1. Home
  2. KNSA vs NTCT Comparison

KNSA vs NTCT Comparison

Compare KNSA & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • NTCT
  • Stock Information
  • Founded
  • KNSA 2015
  • NTCT 1984
  • Country
  • KNSA United Kingdom
  • NTCT United States
  • Employees
  • KNSA N/A
  • NTCT N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • NTCT EDP Services
  • Sector
  • KNSA Health Care
  • NTCT Technology
  • Exchange
  • KNSA Nasdaq
  • NTCT Nasdaq
  • Market Cap
  • KNSA 2.0B
  • NTCT 1.7B
  • IPO Year
  • KNSA 2018
  • NTCT 1999
  • Fundamental
  • Price
  • KNSA $26.03
  • NTCT $21.61
  • Analyst Decision
  • KNSA Strong Buy
  • NTCT Hold
  • Analyst Count
  • KNSA 6
  • NTCT 1
  • Target Price
  • KNSA $38.00
  • NTCT $25.00
  • AVG Volume (30 Days)
  • KNSA 677.6K
  • NTCT 426.5K
  • Earning Date
  • KNSA 04-29-2025
  • NTCT 05-08-2025
  • Dividend Yield
  • KNSA N/A
  • NTCT N/A
  • EPS Growth
  • KNSA N/A
  • NTCT N/A
  • EPS
  • KNSA N/A
  • NTCT N/A
  • Revenue
  • KNSA $481,166,000.00
  • NTCT $822,679,000.00
  • Revenue This Year
  • KNSA $37.21
  • NTCT $0.22
  • Revenue Next Year
  • KNSA $1.53
  • NTCT $2.04
  • P/E Ratio
  • KNSA N/A
  • NTCT N/A
  • Revenue Growth
  • KNSA 59.45
  • NTCT N/A
  • 52 Week Low
  • KNSA $17.38
  • NTCT $17.10
  • 52 Week High
  • KNSA $28.56
  • NTCT $27.89
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 63.21
  • NTCT 61.28
  • Support Level
  • KNSA $25.97
  • NTCT $19.98
  • Resistance Level
  • KNSA $28.56
  • NTCT $22.34
  • Average True Range (ATR)
  • KNSA 1.24
  • NTCT 0.64
  • MACD
  • KNSA 0.36
  • NTCT 0.13
  • Stochastic Oscillator
  • KNSA 71.70
  • NTCT 70.45

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

Share on Social Networks: